Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease With a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies Based on Multi-center Collaboration in China

NCT05940363 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT05940363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05940363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease With a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies Based on Multi-center Collaboration in China
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
June 1, 2026
Enrollment
9,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease in pregnancy, fetal echocardiography, prenatal diagnosis